IRIS
LUZZA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.239
EU - Europa 1.782
AS - Asia 1.606
SA - Sud America 96
AF - Africa 22
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
Totale 6.772
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.110
SG - Singapore 998
IT - Italia 706
DE - Germania 345
CN - Cina 312
GB - Regno Unito 234
SE - Svezia 148
FI - Finlandia 141
CA - Canada 109
BR - Brasile 81
IN - India 77
NL - Olanda 63
IR - Iran 56
HK - Hong Kong 30
JP - Giappone 27
RU - Federazione Russa 22
PL - Polonia 18
TR - Turchia 18
AU - Australia 17
ES - Italia 16
MX - Messico 15
BD - Bangladesh 14
CZ - Repubblica Ceca 14
TW - Taiwan 13
UA - Ucraina 13
FR - Francia 12
IL - Israele 10
PK - Pakistan 9
RO - Romania 9
VN - Vietnam 8
ZA - Sudafrica 8
AT - Austria 7
IE - Irlanda 7
IQ - Iraq 7
EU - Europa 6
CL - Cile 5
SA - Arabia Saudita 5
ID - Indonesia 4
PH - Filippine 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
EC - Ecuador 3
EG - Egitto 3
GR - Grecia 3
HU - Ungheria 3
LT - Lituania 3
OM - Oman 3
PE - Perù 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BE - Belgio 2
CI - Costa d'Avorio 2
CU - Cuba 2
DK - Danimarca 2
KE - Kenya 2
MA - Marocco 2
MG - Madagascar 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
UY - Uruguay 2
AZ - Azerbaigian 1
CR - Costa Rica 1
EE - Estonia 1
HN - Honduras 1
JM - Giamaica 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
NO - Norvegia 1
PY - Paraguay 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 6.772
Salva come PNG Salva come JPEG
Città #
Chandler 533
Singapore 453
Munich 292
Santa Clara 285
Milan 243
Chicago 228
Princeton 211
Lawrence 210
London 199
Wilmington 132
Ashburn 89
Ottawa 82
Helsinki 80
Des Moines 68
Boardman 46
Turku 43
Shanghai 37
Rome 35
Catanzaro 33
Los Angeles 31
Guangzhou 29
Naples 29
Redwood City 27
Cittanova 22
Hanover 22
Hong Kong 20
Pune 20
Mumbai 19
Norwalk 19
Beijing 16
Redmond 16
New York 15
Palermo 14
São Paulo 14
The Dalles 14
Brooklyn 13
Shenzhen 13
Bari 12
Mendicino 12
Osaka 12
Phoenix 12
San Francisco 12
Jyväskylä 11
Montreal 11
San Nicola Manfredi 10
Tokyo 10
Warsaw 10
Cosenza 9
Olomouc 9
Praia A Mare 9
Charlotte 8
Council Bluffs 8
Dhaka 8
Istanbul 8
Jiaxing 8
Stockholm 8
Tehran 8
Amsterdam 7
Collegeville 7
Dublin 7
Assago 6
Atlanta 6
Boston 6
Central 6
Chennai 6
Horia 6
Jerusalem 6
Vienna 6
Wuhan 6
Clearwater 5
Dallas 5
Hangzhou 5
Johannesburg 5
Maletto 5
Nanjing 5
Reggio Calabria 5
Siena 5
Taipei 5
Toronto 5
Wuxi 5
Zabki 5
Ann Arbor 4
Belo Horizonte 4
Buffalo 4
Elk Grove Village 4
Fairfield 4
Hanoi 4
Potenza 4
Rende 4
Selargius 4
Shenyang 4
Sydney 4
West Jordan 4
Xi'an 4
Alhambra 3
Ankara 3
Arequipa 3
Aversa 3
Bade District 3
Belgrade 3
Totale 4.052
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 210
Association between higher duodenal levels of the fructose carrier glucose transporter-5 and nonalcoholic fatty liver disease and liver fibrosis 157
Dietary polyphenolsand non-alcoholic fatty liver disease 75
Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitis 67
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 57
The role of gluten-free diet in nonalcoholic fatty liver disease development 57
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 56
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 55
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 51
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 50
7-Ketolithocholic acid administration in man: effects on biliary lipid composition, serum bile acid pattern and evaluation of the cholelitholytic potential 48
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 48
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopiche di mucosa gastrica antrale 47
Antral nodularity identifies Helicobacter pylori infected children with higher grades of gastric inflammation 47
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 47
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 46
Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study 45
Effects of Mediterranean diet supplemented with sylibin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease 45
Altered IgG4 renal clearance in patients with inflammatory bowel diseases. Evidence for a subclinical impairment of protein charge renal selectivity 44
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 44
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 44
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 43
Bioactive interleukin-18 expression is up-regulated in Crohn’s disease 43
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopicher di mucosa gastrica antrale 43
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 42
Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia. 42
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 42
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis 41
Alcohol consumption survey in an outpatient center of gastroenterology in southern Italy 41
Ancient wheats: beneficial effects on insulin resistance 41
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 41
Evaluation of serum calprotectin as novel biomarker in psoriatic patients: a prospective pilot study 40
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 40
La calcolosi della colecisti 40
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 39
Internal medicine Magna Græcia network for the management of hepatocellular carcinoma. 39
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 39
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 39
Antral nodularity identifies children infected with Helicobacter pylori with higher grades of gastric inflammation 39
Epidemiology of Coronavirus Disease Outbreak: The Italian Trends. 39
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 39
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. 39
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 38
Helicobacter pylori infection in children with celiac disease: prevalence and clinicopathological features 38
High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients 38
Ruolo della colonscopia e delle biopsie multiple nella sorveglianza dei pazienti affetti da colite ulcerosa di lunga durata 38
Antibacterial drugs in Crohn's disease 38
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 38
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 37
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 36
A pathogenetic link between non-alcoholic fatty liver disease and celiac disease 36
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 36
Gut microbiota and non-alcoholic fatty liver disease 36
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature 35
Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7 35
Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease 35
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum 34
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study 34
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 34
Testing for serum IgG antibodies to Helicobacter pylori cytotoxin-associated protein detects children with higher grades of gastric inflammation 34
Low prevalence of p-ANCA in unaffected relatives of patients with ulcerative colitis from a Mediterranean area 34
Bone mineralization in celiac disease 34
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials 33
Circulating D dimer in inflammatory bowel disease 33
Gut microbiota changes and chronic hepatitis C virus infection 33
Trattamento medico della litiasi colesterolica 33
Bioactive IL-18 expression is up-regulated in Crohn's disease 33
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 32
Follow-up clinico-endoscopico in 32 casi di adenoma maligno del colon 32
Interazione Ospite-Batterio 32
Colite ulcerosa: problemi di istopatologia 32
Antral nodularity and positive CagA serology are distinct and relevant markers of severe gastric inflammation in children with Helicobacter Pylori infection 32
Hepatitis C virus-induced hepatocellular carcinoma: a narrative review 31
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients 31
Helicobacter pylori transmission and Hepatitis A 31
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 30
Emorragia intestinale da diverticolo ulcerato del tenue. Descrizione di un caso clinico 30
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization 30
Suggestion against an oral-oral route of transmission for Helicobacter pylori infection: a seroepidemiological study in a rural area. 30
The prevalence of Helicobacter pylori infection is not increased in children with celiac disease. 30
Gastriti acute e croniche 30
The therapy of cholesterol gallstones with bile acids 30
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori 30
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists 30
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 30
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers 29
Changes in the mucosal expression of interleukin 15 in Helicobacter pylori associated gastritis 29
Endoscopy personnel and Helicobacter pylori infection 29
Smoking, alcohol and coffe consumption, and H.pylori infection 29
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 29
Evidence favouring the gastro-oral route in the transmission of Helicobacter pylori infection in children. European Journal of Gastroenterology and Hepatology 29
Interleukin-12 is expressed and actively released by Crohn's desease intestinal lamina propria mononuclear cells 29
Up-regulation of the IL-12 receptor beta-2 in Crohn's disease 29
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells 29
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 28
Isotypic analysis of specific antibody response in serum, saliva, gastric and rectal homogenates of Helicobacter pylori infected patients 28
Evaluation of a commercial serological kit for detection of salivary immunoglobulin G to Helicobacter pylori 28
Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators 28
Seroepidemiology of Helicobacter pylori infection and hepatitis A in a rural area: evidence against a common mode of transmission 28
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 28
Totale 4.056
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.632
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021229 35 11 3 38 20 17 15 26 47 10 4 3
2021/2022568 13 11 16 108 54 8 20 135 54 40 89 20
2022/20231.896 426 60 72 159 186 146 31 151 291 194 147 33
2023/2024952 223 98 71 63 32 219 34 61 45 26 27 53
2024/20252.934 386 182 176 67 173 388 192 155 421 90 250 454
2025/2026218 218 0 0 0 0 0 0 0 0 0 0 0
Totale 7.050